Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Healthy: early-phase trial registry
225 of 1,096 indexed Healthy trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2 of 28,963 conditions by registered trial count.
1,096 US clinical trials · 225 currently recruiting · #2 of 28,963 conditions by registered trial count
Healthy: 1,096 US clinical trials tracked, 225 recruiting.
Healthy is the subject of 1,096 registered US clinical trials on ClinicalTrials.gov, 225 of them currently open to new participants. 43 are in Phase 3-4 (later-stage) and 546 in Phase 1-2 (earlier-stage). The most active sponsor is Eli Lilly and Company, running 55 of these trials.
Open enrollment, early-phase tilt
Healthy has 1,096 registered US clinical trials, 225 of them open to new participants right now, about 21% of the total.
- 225
- recruiting participants now
- 21%
- of trials open to enrollment
- 43
- in Phase 3-4 (later-stage)
- 55
- top sponsor: Eli Lilly and Company
Corpus placement: #2 of 28,963 conditions by registered trial count on ClinicalTrials.gov-derived indexes. Registry reference only, not medical advice.
Key findings
What ClinicalTrials.gov does not surface for Healthy on its own pages , computed from the registry mirror as of 2026-07-11. Each line carries its own denominator so it can be quoted as it stands.
-
Healthy is recruiting below its size-band peers.
225 of 1,096 indexed trials (20.5%) are open to enrollment, against a 37.2% average across 135 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Healthy trials is spread across many organizations.
Eli Lilly and Company accounts for 55 of 1,096 trials (5%). 429 distinct sponsors appear on at least one study for this condition label.
-
Most Healthy trials plan to enrol fewer than 100 people.
Median target enrolment is 40 among the 1,091 trials that report a genuine target (sentinel values excluded). 851 of those (78%) plan for fewer than 100 participants.
-
Healthy research is mostly interventional.
905 interventional and 191 observational studies make up this index (82.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
1,096 total, page 20 of 22
Effects of Ethanol on Oxycodone Pharmacokinetics in Healthy Volunteers
Pain Therapeutics
NCT02165930
Evaluation of a Neck Strengthening Program to Reduce the Risk of Sport-related Concussion
University of Michigan
NCT02455037
Amino Acid Profile and Muscle Protein Synthetic Response to Consuming Meat or Plant-based Alternatives
University of California, Davis
NCT04784806
Effects of Tolvaptan in Healthy Adults
Northwestern University
NCT01973140
The Effect of Cinacalcet on Gastric Acid Output in Healthy Subjects
Tufts University
NCT00336739
Study to Compare the Pharmacokinetics of AC 1202 and Two Doses of AC-SD-01 on Ketone Body Production
Cerecin
NCT03063645
A Study of [¹⁴C]-LY3484356 in Healthy Female Participants
Eli Lilly and Company
NCT04991766
A Single Oral Dose Study Of PF-06427878 In Healthy Adult Subjects
Pfizer
NCT02208284
PT2385-102 Food Effect Study of PT2385 in Healthy Volunteers
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
NCT02553356
Study of Danicopan in Participants With Normal Kidney Function and Participants With Kidney Dysfunction
Alexion Pharmaceuticals
NCT04935294
A Study to Evaluate the Effect of Omeprazole on the Pharmacokinetics of BMS-986205 in Healthy Participants
Bristol-Myers Squibb
NCT03936374
Evaluation of PK of AC-1204 Mixed in Water, AC-1202 Mixed in Water, and AC-1202 Mixed in Ensure® on Ketone Body Production
Cerecin
NCT02959710
A Study of Effects of Selpercatinib (LY3527723) on Midazolam in Healthy Participants
Eli Lilly and Company
NCT05338476
Accuracy of Noninvasive Pulse Oximeter Sensor (MightySat RX)
Masimo Corporation
NCT03125135
Safety and Tolerability Comparison of Immediate and Controlled Release Formulations of Ecopipam
Emalex Biosciences
NCT01408394
A Study of Lithium and Enlicitide in Healthy Adult Participants (MK-0616-034)
Merck Sharp & Dohme
NCT06719544
T Cell Responses to Various Levels of Exercise Stress
University of Kansas
NCT06638684
A Clinical Study of Calderasib (MK-1084) With Rosuvastatin and Metformin in Healthy People (MK-1084-016)
Merck Sharp & Dohme
NCT07222098
Study to Assess Blood Levels of Itraconazole During a Two-Week Period
Stiefel, a GSK Company
NCT00695071
A Target Occupancy Study With Ritlecitinib.
Pfizer
NCT05128058
Developing a Biomarker Panel to Assess Choline Nutritional Status
University of North Carolina, Chapel Hill
NCT03234062
A Study of [14C]-LY4065967 in Healthy Participants
Eli Lilly and Company
NCT07039045
Multi-organ Transit Time Acquisition Using Contrast Ultrasound
Vanderbilt University Medical Center
NCT05135169
Phase I Study of PSD502 (Lidocaine Prilocaine Spray) Applied to the Glans Penis up to Three Times a Day for 21 Days in Healthy Male Volunteers
Plethora Solutions
NCT00483990
Human Perception on Medical Extended Reality Devices
Food and Drug Administration (FDA)
NCT05479019
Meals and Grazing Study
Fred Hutchinson Cancer Center
NCT02548026
A Study of [14C]-LY3866288 in Healthy Participants
Eli Lilly and Company
NCT06644378
Phyllantus Amarus for the Protection of Liver Health
Biotropics Malaysia Berhad
NCT03349697
Acute Effect of Three Neuroactive Drugs Measured by Magnetoencephalography (MEG), Electroencephalography (EEG) and the Synchronous Neural Interaction Test
Orasi Medical
NCT00972985
Mobile Cardiac Telemetry (MCT) Study
Baxter Healthcare Corporation
NCT07158333
Exploratory Trial to Evaluate Premature Endothelial Dysfunction in Early Rheumatoid Arthritis(RA)Compared to Patients With Established RA, and Normal Subjects
Orrin M Troum, M.D. and Medical Associates
NCT01499732
Pharmacokinetic Study of SP-103 in Healthy Adult Human Subjects
Scilex Pharmaceuticals
NCT04819581
Study to Evaluate the Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) in Elderly Subjects
Massachusetts General Hospital
NCT01274598
Exploratory Study Using Positron Emission Tomography With TS-121 and [11C]TASP0410699 in Healthy Adult Male Subjects
Taisho Pharmaceutical R&D
NCT02448212
A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LOXO-305) and Different Formulations of Midazolam in Healthy Participants
Eli Lilly and Company
NCT06180967
Vaccine to Prevent West Nile Virus Disease
National Institute of Allergy and Infectious Diseases (NIAID)
NCT00106769
A Randomized, Two-way, Crossover Study to Estimate the Relative Bioavailability of a Controlled-release Formulation of Oxycodone (40 mg) With Sequestered Naltrexone Compared With Immediate-release Oxycodone Tablets (20 mg) in Healthy Volunteers
Pfizer
NCT01677065
Bioavailability of Golden Rice Carotenoids in Humans
Tufts University
NCT00680355
Glycemic Index of Table Grape Varietals
University of California, Davis
NCT03248609
Non-intrusive Detection of Temporary Neurologic Impairment By Opioids
Mayo Clinic
NCT04223609
A Study to Compare Zavegepant Concentration Using Samples Collected From the Vein Versus Patient-Centric Microsampling
Pfizer
NCT05948085
A Multiple-Dose Pharmacokinetics Study of Two Gefapixant (AF-219/MK-7264) Formulations
Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
NCT02492776
The Effects of Pre-Loaded Betaine Supplementation on Thermoregulation and Exercise Metabolism in the Heat
Florida State University
NCT04585295
Phase 1 Study in Healthy Subjects to Evaluate the Effect of Rifampin on the Pharmacokinetics of IPI-145
SecuraBio
NCT01947777
Study to Evaluate the Effect of Eliglustat on the Pharmacokinetics, Safety and Tolerability of Metoprolol in Healthy Adults
Genzyme, a Sanofi Company
NCT01659944
Phase 1 Study in Healthy Subjects to Evaluate the Effect of IPI-145 on the Pharmacokinetics of Midazolam
SecuraBio
NCT01925911
A Phase I Study to Assess the Pharmacokinetics of Metformin When Administered Alone and in Combination With Vandetanib
Sanofi
NCT01551615
Desaturation Validation of INVSENSOR00038
Masimo Corporation
NCT04017611
Controlled Acute Hypoxia Study - Abbreviated Sensor Line
Medtronic - MITG
NCT02216344
KickStart30: A 30-Day Intervention for Patients With Rheumatoid Arthritis (RA)
University of Texas at Austin
NCT03993548
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 518 |
| Phase 2 | 28 |
| Phase 3 | 11 |
| Phase 4 | 32 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
What is open for Healthy right now
225 recruiting of 1,096 indexed (21% open).
Phase mix: 43 late (III/IV) vs 546 early (I/II) (early-phase heavy).
Top sponsor: Eli Lilly and Company (55 trials), 9 others listed. 50 shown below, recruiting first. #2 of 28,963 conditions by registered trial count.
How open-enrollment share is computed
Open share is recruiting_count divided by trial_count for this condition label in the public registry export. Status can change between pulls; treat the figure as a snapshot of research attention, not treatment availability.
Frequently Asked Questions
How many clinical trials are there for Healthy?
PlainTrial tracks 1,096 US clinical trials for Healthy, of which 225 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Healthy?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.